Improving Care Through Improv: Promoting Mastery in the Moment

June 10, 2025 updated by: Candace Kemp, Georgia State University
The goals of this clinical trial are to: 1) refine the training program, "Improving Care though Improv;" and 2) test the program for its influence self-perceived caregiving mastery (i.e., how persons assess their ability to provide care) among informal caregivers of persons living with moderate dementia. Forty-three informal caregivers will be involved in testing the training program. These individuals will be assigned to groups of between 8 to12 caregivers and take part in weekly 2-hour sessions held over a 4-week period. These caregivers will be taught improvisational (improv) theater skills, which involves being in the moment, self-awareness, and responsiveness to others. This group also will be asked to answer surveys questions about themselves and the person receiving care at three timepoints and invited to provide feedback on their training experiences.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

43

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Georgia
      • Atlanta, Georgia, United States, 30302
        • Georgia State University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Actively engaged in the care of community-dwelling persons living with moderate dementia (4 or 5 on a 7-point dementia-staging scale) who is not likely to be institutionalized within the next 6 months
  • Able to attend at least 3 of the 4 in-person sessions
  • Ability to communicate in English

Exclusion Criteria: Potential participants were excluded if they did not meet the above criteria or anticipated moving their person to a skilled nursing facility within the next 6 months.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Informal Caregivers of Persons Living with Dementia
Participants will receive the training program, "Improving Care through Improv." This involves four weekly 2-hour in-person training sessions.
This intervention for informal caregivers consists of training that will introduce participants to improvisational (improv) theatre and teach its core communication skills.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pearlin Mastery, Loss, and Competence: Caregiver Competence Subscale
Time Frame: at baseline, upon training completion (Week 4), and three months post baseline.
4-item Likert-type scale; scores range from 4 to 16 with higher scores indicating greater feelings of competence.
at baseline, upon training completion (Week 4), and three months post baseline.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Perceived Stress Scale
Time Frame: at baseline, upon training completion (Week 4), and three months post baseline.
14-item Likert-type scale. Scores range from 0 to 56 with higher scores indicating greater stress.
at baseline, upon training completion (Week 4), and three months post baseline.
Center for Epidemiological Studies-Depression Scale
Time Frame: at baseline, upon training completion (Week 4), and three months post baseline.
20-item Likert-type scale. Scores range from 0 to 60 with higher scores indicating greater depression.
at baseline, upon training completion (Week 4), and three months post baseline.
State-Trait Anxiety Inventory
Time Frame: at baseline, upon training completion (Week 4), and three months post baseline.
20-item Likert-type scale. Scores range from 20 to 80 with higher scores indicating greater anxiety.
at baseline, upon training completion (Week 4), and three months post baseline.
Zarit Burden Inventory
Time Frame: at baseline, upon training completion (Week 4), and three months post baseline.
22-item scale with 4-point Likert scale responses. Scores range from 0 to 88 with higher scores indicating greater burden.
at baseline, upon training completion (Week 4), and three months post baseline.
Quality of Life-Alzheimer's Disease Scale
Time Frame: at baseline, upon training completion (Week 4), and three months post baseline.
13 items with a 4-point Likert scale. Scores range from 13 to with 52 with higher scores indicating greater quality of life among persons living with dementia
at baseline, upon training completion (Week 4), and three months post baseline.
Revised Memory and Behavioral Problems Checklist - FREQUENCY
Time Frame: at baseline, upon training completion (Week 4), and three months post baseline.
24-item scale with 4-point Likert scale responses. Scores range from 0 to 96 with higher scores indicating greater behavioral expressions observed by caregivers among persons living with dementia.
at baseline, upon training completion (Week 4), and three months post baseline.
Revised Memory and Behavioral Problems Checklist - REACTION
Time Frame: at baseline, upon training completion (Week 4), and three months post baseline.
24-item scale with 4-point Likert scale responses. Scores range from 0 to 96 with higher scores indicating greater behavioral expressions observed by caregivers among persons living with dementia.
at baseline, upon training completion (Week 4), and three months post baseline.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Candace L Kemp, PhD, Georgia State Univeristy

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 25, 2023

Primary Completion (Actual)

May 20, 2024

Study Completion (Actual)

May 20, 2024

Study Registration Dates

First Submitted

August 10, 2023

First Submitted That Met QC Criteria

August 10, 2023

First Posted (Actual)

August 18, 2023

Study Record Updates

Last Update Posted (Actual)

June 11, 2025

Last Update Submitted That Met QC Criteria

June 10, 2025

Last Verified

June 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • P30AG064200 (U.S. NIH Grant/Contract)
  • DBSR-11114 (Other Identifier: NIA CROMS)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

Data from this study will be made available to qualified researchers through a data sharing agreement that is consistent with NIH data sharing policies, as well as policies and practices established by the Roybal Center for Dementia Caregiving Mastery at Emory University. The data to be collected include common data elements, including the Caregiver Mastery Scale developed by Pearlin and colleagues, as well as demographic characteristics. Although these data will be de-identified prior to release for sharing, there remains a possibility of deductive disclosure of participants with unusual characteristics. Therefore, this data sharing agreement will require: 1) a commitment only to use the data for research purposes and not to identify any individual participant; 2) a commitment to securing the data using appropriate computer technology; and 3) a commitment to destroy or return the data after analyses are completed.

IPD Sharing Time Frame

Study data will be made available no later than the on-line publication date of the main findings from the final dataset.

IPD Sharing Access Criteria

Researchers must qualify and enter into a data sharing agreement. The agreement requires: 1) a commitment only to use the data for research purposes and not to identify any individual participant; 2) a commitment to securing the data using appropriate computer technology; and 3) a commitment to destroy or return the data after analyses are completed.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Caregiver Burden

Clinical Trials on Training program pilot

Subscribe